The interaction of the antibacterial drug, vancomycin with microcavity suspended lipid bilayers (MSLB) was investigated using non‐Faradaic electrochemical impedance spectroscopy (EIS). Five MSLB compositions were prepared with increasing complexity at gold substrates: DOPC, DOPC:Chol, DOPC:SM:Chol, mammalian plasma membrane mimetic (MPM), and E. coli polar lipid extract. The latter two, are intended to mimic eukaryotic and bacterial inner membrane compositions respectively. The extent of vancomycin association and the impact drug association has on the electrochemical properties of the membrane depended on biomembrane composition. Trends were similar across all membranes but the E. coli membrane composition. Vancomycin increased membrane resistance and decreased capacitance in a saturable, concentration dependent manner, but for E. coli membrane resistance change was negligible and capacitance increased. Membrane resistance data was fit to the Langmuir‐Freundlich model to give quantitative insight into the relative extent of association of drug with membrane as a function of membrane composition. Overall, electrochemical data indicates that vancomycin associates at the interface of lipid membranes rather than penetrates the layer and this is promoted by the presence of anionic phospholipid. Interestingly, co‐incubation of the E. coli extract bilayer with both rifampicin and vancomycin, known to act synergistically, significantly promotes vancomycin association to E. coli membrane.